Floatz logo

AZURIN-P28

Teratoid Tumor, Atypical

Pediatric Brain Tumor Consortiumprotein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Teratoid Tumor, Atypical cohort.

Asset / SponsorPhaseRating
Tazemetostat
Epizyme, Inc.
Phase 2B
Cytosin-Arabinosid
Medical University of Vienna
Phase 2CCC
Cyclophosphamide
Medical University of Vienna
Phase 2CCC
Thalidomide
Medical University of Vienna
Phase 2CCC
Dfn-15
Medical University of Vienna
Phase 2CCC

View all 39 →

Same molecule, other indications

AZURIN-P28 is also rated in:

childhood choroid plexus neoplasmDormant
CC
Indicative ·
47 / 100
View asset →
anaplastic oligodendrogliomaDormant
CC
Indicative ·
47 / 100
View asset →
brainstem neoplasmDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →